Anixa Biosciences, Inc.

ANIX · NASDAQ
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Assets
Cash & Equivalents$1,495$1,910$1,053$1,271
Short-Term Investments$14,534$13,687$16,202$18,653
Receivables$0$0$0$173
Inventory$0$0$0$0
Other Curr. Assets$1,420$1,169$1,431$1,265
Total Curr. Assets$17,449$16,766$18,686$21,362
Property Plant & Equip (Net)$202$211$220$229
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$202$211$220$229
Other Assets$0$0$0$0
Total Assets$17,651$16,977$18,906$21,591
Liabilities
Payables$276$284$600$525
Short-Term Debt$39$37$36$29
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,751$1,566$1,363$1,946
Total Curr. Liab.$2,066$1,887$1,999$2,500
LT Debt$174$184$194$203
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$174$184$194$203
Other Liabilities$0$0$0$0
Cap. Leases$0$221$230$232
Total Liabilities$2,240$2,071$2,193$2,703
Equity
Pref Stock$0$0$0$0
Common Stock$328$322$322$322
Retained Earnings-$248,982-$246,724-$243,934-$240,750
AOCI$0$0$0$0
Other Equity$265,249$262,470$261,464$260,426
Total Equity$16,595$16,068$17,852$19,998
Supplemental Information
Minority Interest-$1,184-$1,162-$1,139-$1,110
Total Liab. & Tot. Equity$17,651$16,977$18,906$21,591
Net Debt-$1,282-$1,689-$823-$1,039